Literature DB >> 9753061

Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line.

M Daibata1, T Taguchi, H Taguchi, I Miyoshi.   

Abstract

Human herpesvirus 6 (HHV-6) genome has been found in several human lymphoid malignancies, but configuration of the HHV-6 genome has not been well delineated. We established the HHV-6-positive, Epstein-Barr virus-negative Burkitt's lymphoma cell line Katata. In this study we investigated the status of the HHV-6 genome in Katata cells. Neither linear nor circular HHV-6 DNA was detected by Gardella gel analysis. The fluorescence in situ hybridization technique enabled us to directly visualize the integrated HHV-6 DNA at the single-cell level. Only one integrated site of viral DNA was detected in metaphase chromosomes and it was preferentially located at the long arm of chromosome 22 (22q13). Treatment of the cells with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) or with calcium ionophore A23187 led to induction of the HHV-6 immediate-early gene as well as the late gene. Sodium n-butyrate also gave rise to expression of the HHV-6 genes. The TPA inducibility was synergistically enhanced when combined with A23187 or n-butyrate. Our study provides, for the first time, an in vitro model system of latent HHV-6 infection whose genome is integrated into host DNA of lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753061     DOI: 10.1046/j.1365-2141.1998.00903.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

1.  The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Authors:  Jesse H Arbuckle; Maria M Medveczky; Janos Luka; Stephen H Hadley; Andrea Luegmayr; Dharam Ablashi; Troy C Lund; Jakub Tolar; Kenny De Meirleir; Jose G Montoya; Anthony L Komaroff; Peter F Ambros; Peter G Medveczky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 3.  The molecular biology of human herpesvirus-6 latency and telomere integration.

Authors:  Jesse H Arbuckle; Peter G Medveczky
Journal:  Microbes Infect       Date:  2011-03-31       Impact factor: 2.700

4.  Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration.

Authors:  Shella Gilbert-Girard; Annie Gravel; Sara Artusi; Sara N Richter; Nina Wallaschek; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 5.  Herpesviruses and chromosomal integration.

Authors:  Guillaume Morissette; Louis Flamand
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 6.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 7.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Ultrastructural study of the morphogenesis of human herpesvirus 6 type B in human T-lymphotropic virus type I-producing lymphoid cells.

Authors:  Yuji Ohtsuki; Masanori Daibata; Kentaro Bandobashi; Gang-Hong Lee; Mutsuo Furihata; Akihito Yokoyama; Isao Miyoshi
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

9.  Mapping the telomere integrated genome of human herpesvirus 6A and 6B.

Authors:  Jesse H Arbuckle; Shara N Pantry; Maria M Medveczky; Joshua Prichett; Kristin S Loomis; Dharam Ablashi; Peter G Medveczky
Journal:  Virology       Date:  2013-05-04       Impact factor: 3.616

10.  Inflammatory Cytokine Profile in Individuals with Inherited Chromosomally Integrated Human Herpesvirus 6.

Authors:  Daniel P Weschke; Wendy M Leisenring; Richard L Lawler; Terry Stevens-Ayers; Meei-Li Huang; Keith R Jerome; Danielle M Zerr; John A Hansen; Michael Boeckh; Joshua A Hill
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-31       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.